eKRAS

Early assessment of KRAS mutations in patients with Congenital Lung Malformations by liquid biopsy; a pilot study - eKRAS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON61414

Enrollment

Registered

2025-12-31

Start date

2026-08-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Pulmonary Airway Malformation (CPAM) Cysts (cavities filled with air or fluid) in the lung

Interventions

blood sample collection&nbsp

Eligibility

Age

2 Years to 99 Years

Inclusion criteria

Inclusion criteria: Congenital Lung Malformation (CLM)

Exclusion criteria

Exclusion criteria: for blood: not able to obtain blood

Design outcomes

Primary

Measure	Time frame
The presence or absence of detectable KRAS mutations in blood and/or BAL fluid	—

Countries

Netherlands

Contacts

Public ContactJ Hemelaar

Erasmus MC, Universitair Medisch Centrum Rotterdam

indieningen.long@erasmusmc.nl0633343648

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 10, 2026